- Active ingredient:
- Sitagliptin 50 mg (54.47 mg as sitagliptin hydrochloride) Metformin hydrochloride 500 mg
- Pharmaceutical form:
- Film-coated tablet, oval, light pink film-coated tablet.
- Route of administration:
- SANOSITA PLUS should generally be administered twice daily with meals, in conjunction with a gradual dose escalation, to reduce metformin-related gastrointestinal (GI) side effects.